Mercator gets $6.5M boost to market microinfusion devices

05/31/2013 | (Boston)

Mercator MedSystems has obtained $6.5 million in a Series B financing round, which it will use in part to begin sales of its Cricket and Bullfrog microinfusion devices in the U.S., Europe and Australia. The devices, which already have FDA clearance and CE mark approval in Europe, are used to safely deliver drugs to deep tissue through blood vessel walls.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA